Insulin glulisine in the management of diabetes
Satoru Yamada1,21Diabetes Center, Kitasato Institute Hospital, Tokyo, Japan; 2Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanAbstract: Insulin glulisine is appealing in principle, but the advantages of this drug over the other rapid-acting insulin analogs are still...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-07-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity |
| Online Access: | http://www.dovepress.com/insulin-glulisine-in-the-management-of-diabetes-a3337 |
| _version_ | 1797936533658927104 |
|---|---|
| author | Satoru Yamada |
| author_facet | Satoru Yamada |
| author_sort | Satoru Yamada |
| collection | DOAJ |
| description | Satoru Yamada1,21Diabetes Center, Kitasato Institute Hospital, Tokyo, Japan; 2Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanAbstract: Insulin glulisine is appealing in principle, but the advantages of this drug over the other rapid-acting insulin analogs are still relatively unknown. The frequency of hypoglycemia, convenience in the timing of administration, and improvements in terms of HbA1c seem similar among the rapid-acting insulin analogs, including insulin glulisine. Only properly randomized long-term clinical studies with insulin glulisine will reveal the true value of this novel insulin analog.Keywords: insulin analog, rapid-acting insulin, trometamol, polysorbate 20 |
| first_indexed | 2024-04-10T18:31:03Z |
| format | Article |
| id | doaj.art-81881391964b4acc90bccbf4114255c3 |
| institution | Directory Open Access Journal |
| issn | 1178-7007 |
| language | English |
| last_indexed | 2024-04-10T18:31:03Z |
| publishDate | 2009-07-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Diabetes, Metabolic Syndrome and Obesity |
| spelling | doaj.art-81881391964b4acc90bccbf4114255c32023-02-02T04:10:47ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072009-07-012009default111115Insulin glulisine in the management of diabetesSatoru YamadaSatoru Yamada1,21Diabetes Center, Kitasato Institute Hospital, Tokyo, Japan; 2Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanAbstract: Insulin glulisine is appealing in principle, but the advantages of this drug over the other rapid-acting insulin analogs are still relatively unknown. The frequency of hypoglycemia, convenience in the timing of administration, and improvements in terms of HbA1c seem similar among the rapid-acting insulin analogs, including insulin glulisine. Only properly randomized long-term clinical studies with insulin glulisine will reveal the true value of this novel insulin analog.Keywords: insulin analog, rapid-acting insulin, trometamol, polysorbate 20http://www.dovepress.com/insulin-glulisine-in-the-management-of-diabetes-a3337 |
| spellingShingle | Satoru Yamada Insulin glulisine in the management of diabetes Diabetes, Metabolic Syndrome and Obesity |
| title | Insulin glulisine in the management of diabetes |
| title_full | Insulin glulisine in the management of diabetes |
| title_fullStr | Insulin glulisine in the management of diabetes |
| title_full_unstemmed | Insulin glulisine in the management of diabetes |
| title_short | Insulin glulisine in the management of diabetes |
| title_sort | insulin glulisine in the management of diabetes |
| url | http://www.dovepress.com/insulin-glulisine-in-the-management-of-diabetes-a3337 |
| work_keys_str_mv | AT satoruyamada insulinglulisineinthemanagementofdiabetes |